Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) a webinar on August 11, 2020 reviewed the challenges and opportunities in developing Covid-19 vaccines.


Tonix CEO Seth Lederman, MD provided a basic understanding of how different vaccine technologies work, and why some vaccines are designed for multi-dose short term immunity, while others are being engineered with precision medicine techniques to provide single dose long-term immunity and to prevent forward transmission, or contagion, an essential need for ending the spread of Covid-19.


The program covered the societal and clinical goals scientists and policymakers face in evaluating various Covid-19 vaccine technologies and strategies for their use.

Investors will be better equipped to understand the latest vaccine headlines.